Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.320
+0.070 (5.60%)
At close: Sep 28, 2026
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $63.93 million as of September 28, 2026. Its market cap has decreased by -27.43% in one year.
Market Cap
63.93M
Enterprise Value
65.29M
Revenue
5.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.32
ChartMarket Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 63.93M, an increase of 222.01%. That is a compound annual growth rate of 12.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 63.93M | -32.64% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 148.32M |
| Vaxart | 110.62M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 76.02M |
| Sangamo Therapeutics | 59.66M |
| Arch Biopartners | 39.40M |
| Biomind Labs | 35.68M |
| ProText Mobility | 31.65M |